1Alzheimer’s disease：the silver tsunami of the 21st centuryAnkita Sarkar, Madison Irwin, Aditi Singh, Matthew Riccetti, Amit Singh693-6972TFP5/TP5 peptide provides neuroprotection in the MPTP model of Parkinson’s diseaseBinukumar BK, Harish C.Pant698-7013Clinical trial perspective for adult and juvenile Huntington’s disease using genetically-engineered mesenchymal stem cellsPeter Deng, Audrey Torrest, Kari Pollock, Heather Dahlenburg, Geralyn Annett, Jan A. Nolta, Kyle D. Fink702-7054Adenosine A2A receptors in neuronal outgrowth：a target for nerve regeneration?Filipa F. Ribeiro, Ana M. Sebasti?o706-7085Coordination of the axonal cytoskeleton during the emergence of axon collateral branchesGianluca Gallo709-7116Antibody-based neuronal and axonal delivery vectors for targeted ligand deliveryKazim A. Sheikh, Gang Zhang712-7147Possible application of apolipoprotein E-containing lipoproteins and polyunsaturated fatty acids in neural regenerationMichinori Matsuo715-7168Self-assembling peptide nanoifbrous hydrogel as a promising strategy in nerve repair after traumatic injury in the nervous systemNa Zhang, Liumin He, Wutian Wu717-7189Cross tolerance：a tread to decipher the code of endogenous global cerebral resistanceAshish Sharma, Rohit Goyal719-72010Focusing on the protective effects of metallothionein-I/II in cerebral ischemiaAbass Eidizadeh, George Trendelenburg721-72211Comparative insights into mitochondrial adaptations to anoxia in brainMatthew E. Pamenter723-72412Iron metabolism, oxidative stress, and neonatal brain injuryQing Lu, Stephen M.Black725-72613Induced pluripotent stem cells for modeling and cell therapy of Parkinson’s diseaseMária Cs?b?nyeiová, ?ubo? Dani?ovi?, ?tefan Polák727-72814Cholinergic input from the pedunculopontine nucleus to the cerebellum：implications for deep brain stimulation in Parkinson’s diseaseEugenio Scarnati, Flora Vitale, Annamaria Capozzo, Paolo Mazzone729-73015Do we need a new levodopa?hTomas Müller731-73216Programmed cell death and natural killer cells in multiple sclerosis：new potential therapeutic targets?Beatrice Macchi, Antonio Mastino733-73417Neurotrophic factors：promising candidates in tissue regenerationNan Xiao735-73618Ischemic penumbra in retina endures:vascular neuropathology is reconciledDavid McLeod737-73919Complementary research in mammals and ifsh indicates MMP-2 as a pleiotropic contributor to optic nerve regenerationKim Lemmens, Inge Van Hove, Lieve Moons740-74220Viral-mediated gene therapy for spinal cord injury (SCI) from a translational neuroanatomical perspectiveAndrew P Tosolini, Renée Morris743-744 